Shionogi - PharmaKB

Shionogi

Shionogi & Company, Limited (塩野義製薬株式会社, Shionogi Seiyaku Kabushiki Kaisha) is a Japanese pharmaceutical company best known for developing Crestor. Medical supply and brand name also uses katakana (シオノギ).

Trade Name	Drug Name	Approved	Patent Expires	Indication
Cognex	Tacrine	1993-09-09		Alzheimer disease
Doribax	Doripenem	2007-10-12		Ventilator-associated pneumonia , Urinary tract infections , Cross infection , Bacterial infections , Intraabdominal infections , Bacterial pneumonia
Fetcroja	Cefiderocol	2020-04-23	2033-2035	Urinary tract infections , Bacterial infections , Gram-negative bacterial infections , Pyelonephritis
Fetroja	Cefiderocol	2019-11-14	2033-2035	Urinary tract infections, Bacterial infections, Gram-negative bacterial infections, Pyelonephritis
Mulpleo (previously lusutrombopag shionogi)	Lusutrombopag	2019-02-18	2024-2031	Thrombocytopenia
Mulpleta	Lusutrombopag	2018-07-31	2024-2031	Thrombocytopenia
Rizmoic	Naldemedine	2019-02-18	2026-2033	Constipation
Rybix	Tramadol	2005-05-05	2030-2040	Pain, Fever, Ankylosing spondylitis, Rheumatoid arthritis, Osteoarthritis, Adenomatous polyposis coli, Dysmenorrhea
Senshio	Ospemifene	2015-01-14	2024-2028	Dyspareunia, Atrophy, Postmenopause, Menopause
Urobak	Sulfamethoxazole	1982-01-01		Mycoses, Toxoplasmosis, Urinary tract infections, Chronic bronchitis, Otitis media, Bacterial infections, Enterobacteriaceae infections, Escherichia coli infections, Bronchitis, Bacterial eye infections, Pneumocystis pneumonia, Staphylococcal infections, Proteus infections, Aids-related opportunistic infections, Klebsiella infections, Protozoan infections, Chlamydiaceae infections, Nocardia infections, Pain, Urological manifestations
Uroplus	Sulfamethoxazole, Trimethoprim	1987-09-28		Mycoses, Toxoplasmosis, Urinary tract infections, Chronic bronchitis, Otitis media, Bacterial infections, Enterobacteriaceae infections, Escherichia coli infections, Bronchitis, Bacterial eye infections, Pneumocystis pneumonia, Staphylococcal infections, Proteus infections, Aids-related opportunistic infections, Klebsiella infections, Protozoan infections, Chlamydiaceae infections, Nocardia infections, Pain, Urological manifestations
Uroplus ss	Sulfamethoxazole, Trimethoprim	1987-09-28		Mycoses, Toxoplasmosis, Urinary tract infections, Chronic bronchitis, Otitis media, Bacterial infections, Enterobacteriaceae infections, Escherichia coli infections, Bronchitis, Bacterial eye infections, Pneumocystis pneumonia, Staphylococcal infections, Proteus infections, Aids-related opportunistic infections, Klebsiella infections, Protozoan infections, Chlamydiaceae infections, Nocardia infections, Pain, Urological manifestations